BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21813289)

  • 1. Sympathetic neuropathy in diabetes mellitus patients does not elicit Charcot osteoarthropathy.
    Christensen TM; Simonsen L; Holstein PE; Svendsen OL; Bülow J
    J Diabetes Complications; 2011; 25(5):320-4. PubMed ID: 21813289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normal blood flow response and vasomotion in the diabetic Charcot foot.
    Shapiro SA; Stansberry KB; Hill MA; Meyer MD; McNitt PM; Bhatt BA; Vinik AI
    J Diabetes Complications; 1998; 12(3):147-53. PubMed ID: 9618070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel FEMASK-score, a histopathologic assessment for destructive Charcot neuropathic arthropathy, reveals intraneural vasculopathy and correlates with progression and best treatment.
    King J; Murie B; Fanburg-Smith JC; Stauch CM; Flemming D; Klein MJ; Frauenhoffer EE; Fritsche M; Smith JD; Elfar J; Aynardi M
    Ann Diagn Pathol; 2020 Aug; 47():151509. PubMed ID: 32619921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective neuropathy and preserved vascular responses in the diabetic Charcot foot.
    Stevens MJ; Edmonds ME; Foster AV; Watkins PJ
    Diabetologia; 1992 Feb; 35(2):148-54. PubMed ID: 1547919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative sweat test in diabetics with neuropathic foot lesions.
    Ahmed ME; Le Quesne PM
    J Neurol Neurosurg Psychiatry; 1986 Sep; 49(9):1059-62. PubMed ID: 3760896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of peripheral sympathetic function by postural vasoconstriction arteriolar reflex and sympathetic skin response in NIDDM patients.
    Cacciatori V; Dellera A; Bellavere F; Bongiovanni LG; Teatini F; Gemma ML; Muggeo M
    Am J Med; 1997 Apr; 102(4):365-70. PubMed ID: 9217618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcaneal bone mineral density in patients with Charcot neuropathic osteoarthropathy: differences between Type 1 and Type 2 diabetes.
    Petrova NL; Foster AV; Edmonds ME
    Diabet Med; 2005 Jun; 22(6):756-61. PubMed ID: 15910628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sympathetic nerve failure in diabetes.
    Watkins PJ; Edmonds ME
    Diabetologia; 1983 Aug; 25(2):73-7. PubMed ID: 6628876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of Syme amputation in surgical treatment of patients with diabetic foot syndrome and Charcot-neuro-osteoarthropathy.
    Eckardt A; Schöllner C; Decking J; Ritter S; Schadmand-Fischer S; Kraus O; Küstner E
    Arch Orthop Trauma Surg; 2004 Apr; 124(3):145-50. PubMed ID: 14872254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of foot deformity in Charcot neuropathic osteoarthropathy.
    Hastings MK; Johnson JE; Strube MJ; Hildebolt CF; Bohnert KL; Prior FW; Sinacore DR
    J Bone Joint Surg Am; 2013 Jul; 95(13):1206-13. PubMed ID: 23824389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autonomic function in neuropathic diabetic patients with foot ulceration.
    Gilmore JE; Allen JA; Hayes JR
    Diabetes Care; 1993 Jan; 16(1):61-7. PubMed ID: 8422834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lower limb venous pressure in diabetic neuropathy.
    Purewal TS; Goss DE; Watkins PJ; Edmonds ME
    Diabetes Care; 1995 Mar; 18(3):377-81. PubMed ID: 7555481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone mineral density in diabetes mellitus patients with and without a Charcot foot.
    Christensen TM; Bülow J; Simonsen L; Holstein PE; Svendsen OL
    Clin Physiol Funct Imaging; 2010 Mar; 30(2):130-4. PubMed ID: 20089075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Confronting a dramatic situation: the charcot foot complicated by osteomyelitis.
    Dalla Paola L
    Int J Low Extrem Wounds; 2014 Dec; 13(4):247-62. PubMed ID: 25123373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Charcot arthropathy of the foot and ankle associated with rheumatoid arthritis.
    Grear BJ; Rabinovich A; Brodsky JW
    Foot Ankle Int; 2013 Nov; 34(11):1541-7. PubMed ID: 23900228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Charcot Foot: A Case Report.
    Phillips A; Rice L
    Nephrol Nurs J; 2022; 49(5):419-425. PubMed ID: 36332122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of off-loading and recurrence rate in Charcot osteo-arthropathy treated with less restrictive regimen with removable walker.
    Christensen TM; Gade-Rasmussen B; Pedersen LW; Hommel E; Holstein PE; Svendsen OL
    J Diabetes Complications; 2012; 26(5):430-4. PubMed ID: 22699112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density and markers of bone turnover and inflammation in diabetes patients with or without a Charcot foot: An 8.5-year prospective case-control study.
    Jansen RB; Christensen TM; Bülow J; Rørdam L; Holstein PE; Jørgensen NR; Svendsen OL
    J Diabetes Complications; 2018 Feb; 32(2):164-170. PubMed ID: 29196119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermoregulatory sudomotor dysfunction and diabetic neuropathy develop in parallel in at-risk feet.
    Sun PC; Lin HD; Jao SH; Chan RC; Kao MJ; Cheng CK
    Diabet Med; 2008 Apr; 25(4):413-8. PubMed ID: 18341593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of the acute Charcot foot in diabetes.
    Rudrappa S; Game F; Jeffcoate W
    Diabet Med; 2012 Jun; 29(6):819-21. PubMed ID: 22587408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.